MATTAWAN, Mich.--(BUSINESS WIRE)--MPI Research, the largest single-site preclinical contract research organization worldwide, is pleased to announce that Tim Derrington is joining MPI Research as President and Chief Operating Officer, effective March 7, 2011.

Derrington brings a wealth of international operational and industry leadership, experience, and specific knowledge for maximizing operational performance, business development, and strategic partnerships. He most recently was Chairman and CEO of Axient Research, a CRO developing clinical research solutions to deliver reliable and accurate patient data to accelerate the development of safe and effective drug and medical treatments.

Prior to Axient, Derrington was the CEO of BioReliance Corp (Invitrogen Corp), a research company providing biologic testing and manufacturing and toxicology services to global pharmaceutical and biopharmaceutical companies that span the product cycle from early preclinical development to licensed production. Over the duration of his career, he has held management positions with Quintiles Transnational Corp (Senior Vice President, Corporate Development); Quintiles Laboratories Worldwide (Chief Operating Officer); Mayo Clinic (Administrative Director-Clinical Trials); and Shell UK Ventures (Managing Director and Project Manager).

Derrington is a graduate of Seale Hayne College, England, and holds an MBA from Henley Management College, Oxfordshire, England.

According to MPI Research Chairman and CEO, William U. Parfet, “As President and COO, Tim Derrington will help us scale our operations and expand our presence globally. He represents the depth that is essential to our top management team, and his knowledge, leadership ability, and industry experience will be among our most valuable assets.”

Please join us in welcoming Tim Derrington to MPI Research!

MPI Research, with global headquarters in Mattawan, Michigan, provides safety evaluation, discovery, bioanalytical, and analytical services to the biopharmaceutical, medical device, animal health, and chemical industries. Scientific knowledge and experience, responsiveness, integrity, trust, teamwork, and dedication to strong and enduring Sponsor relationships are the defining attributes that characterize MPI Research as a high-performance, high-quality organization that is committed to bringing safer and more effective products to the world. Learn more about how we can exceed your expectations at www.mpiresearch.com.

Contacts